Researchers studying gene expression have access to vast amounts of data from cells or tissues. This is thanks to advances in bulk and single-cell RNA-sequencing (RNA-seq) technologies that can ...

BostonGene, developer of the leading AI foundation model for tumor and immune biology, announced results from the FEASY study in collaboration with The University of Texas MD Anderson Cancer Center, ...

Agilent Technologies and BaseSolve announce a co-marketing agreement to offer a U.S.-focused integrated solution for NGS workflows. This collaboration provides a streamlined genomics workflow by ...

Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions, today announced the commercial availability of Evercode™ Whole Transcriptome ...

Scientists can peer into cells to get a limited view of their activity using microscopes and other tools. However, cells and the molecular events within them are dynamic, and developmental processes, ...

Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...

SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced a significant update to the company’s flagship Evercode™ ...